Should we be worried about hepatitis E?

(Stellenbosch University) Hepatitis E gets little press compared to its better-known cousins A, B and C, but Stellenbosch University virologists say we should wake up to how transmission of this virus is changing.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news

Related Links:

AbstractPurposeWe aimed to validate the performance of the hepatitis B-based Hong Kong Liver Cancer (HKLC) staging system compared with the Barcelona Clinic Liver Cancer (BCLC) staging system in Chinese hepatocellular carcinoma (HCC) patients treated with conventional transarterial chemoembolization (TACE) as the initial treatment.Materials and MethodsThe study was approved by the Institutional Review Boards at all participating centers. This retrospective study included 715 patients with HCC who underwent TACE as the initial treatment between January 2008 and December 2016 at three Chinese institutions. All of the patient...
Source: CardioVascular and Interventional Radiology - Category: Radiology Source Type: research
Scientists have honed in on the cause of a rare condition Hepatitis B virus-associated acute liver failure that can kill a patient in a few days.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
Publication date: December 2018Source: Joint Bone Spine, Volume 85, Issue 6Author(s): Julien Paccou, Laetitia Michou, Sami Kolta, Françoise Debiais, Bernard Cortet, Pascal GuggenbuhlAbstractA finding of high bone mineral density (BMD) from routine dual-energy X-ray absorptiometry (DXA) screening is not uncommon. No consensus exists about the definition of high BMD, and T-score and/or Z-score cutoffs of ≥ + 2.5 or ≥ + 4 have been suggested. The many disorders that can result in high BMD are usually classified based on whether the BMD changes are focal vs. generalized or acquired vs. constitu...
Source: Joint Bone Spine - Category: Orthopaedics Source Type: research
Patients older than 50 years should still be screened for hepatocellular carcinoma after the 5 years of therapy for chronic hepatitis B, new research shows.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Source Type: news
The liver is a powerful organ that the hepatitis C virus can affect. The virus causes inflammation and can lead to scarring. The name for scarring of the liver is cirrhosis. People with both conditions may have more risk of liver failure. Learn more about the link between hepatitis C and cirrhosis here.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news
Conclusion As this was only a pilot study, further data collection involving a larger, representative sample of clients should be undertaken to explore these results further. References Bennett, H. et al., 2015. Assessing the Long-Term Impact of Treating Hepatitis C Virus (HCV)-Infected People Who Inject Drugs in the UK and the Relationship between Treatment Uptake and Efficacy on Future Infections. PLoS ONE, 10(5), p.e0125846. Edeghere, O. et al., 2015. Retrospective cohort study of liver transplantation in the United Kingdom between 1994 and 2010: the impact of hepatitis C infection. Public Health, 129(5), pp.509–5...
Source: Alcohol Research UK - Category: Addiction Authors: Tags: Alcohol Insights Source Type: news
Authors: Morillas RM, López Sisamón D Abstract Although the risk of reactivation of hepatitis B in patients treated with immunosuppressants has been known for years and, if there are recommendations, data from some surveys indicate that the study of the serological profile of HBV infection before starting immunosuppressive treatment is not universal practice. Taking into account the serious consequences that the reactivation of the infection with HBV may entail, we believe that it is necessary to disclose the importance of this problem among the health professionals who prescribe these treatments as w...
Source: Medicina Clinica - Category: General Medicine Tags: Med Clin (Barc) Source Type: research
THURSDAY, Nov. 15, 2018 -- Combined treatment with glecaprevir and pibrentasvir (G/P) is highly effective in treating chronic hepatitis C virus (HCV) genotype-1 infections that failed to respond to direct-acting antiviral therapy, according to a...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
Authors: Sghaier I, Zidi S, Mouelhi L, Ghazoueni E, Brochot E, Almawi WY, Loueslati BY Abstract BACKGROUND: Chronic infection with hepatitis B (HBV) and C virus (HCV) is linked with a pro-inflammatory state, predisposing to cirrhosis and liver cancer, particularly hepatocellular carcinoma (HCC). A role for toll-like receptor (TLR) signalling in hepatocarcinogenesis was recently documented. We hypothesised a link TLR3 and TLR4 polymorphisms and HCC, as surrogates for the significance of TLR signalling in the promotion and initiation of HCC. MATERIALS &METHODS: We recruited 174 HCV-infected patients, 100 HBV-...
Source: British Journal of Biomedical Science - Category: Laboratory Medicine Tags: Br J Biomed Sci Source Type: research
This study examined how markers of liver health are associated with mortality in persons without viral hepatitis in the United States. Are liver fat scores useful for metabolic health surveillance?Alimentary Pharmacology &Therapeutics
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
More News: Hepatitis | Infectious Diseases | Virology